Monthly Archives: May 2017

Biopharmaceutical News Week # 20.2017

      Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com       Mergers, Acquisitions and Joint Venture   Thermo Fisher (Waltham, MA, USA) acquires Patheon (Durham, NC, USA), a contract development and manufacturing company for $7.2 billion and becomes a highly competitive biologic contract development and manufacturing organization (CDMO) through direct access to its bioprocessing technologies […]

read more

Biopharmaceutical News Week # 19.2017

      Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com         The US Senate voted 57 to 42 to confirm Dr. Scott Gottlieb as the next FDA commissioner. The biopharmaceutical industry has backed him from the beginning and is happy to endorse someone well known and his views on the agency.     […]

read more

Biopharmaceutical News Week # 17-18.2017

    Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com       Mergers, Acquisitions and Joint Venture   Sosei (Tokyo, Japan) announces its plan to acquire MiNA Therapeutics (London, UK) in buying 25.6% of its equity and an exclusive option to acquire the company for $45 million in cash. Right now MiNA is testing its first […]

read more

Biopharmaceutical News Week # 16.2017

      Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com           Editor’s Note   Biopharmaceutical Newsweek letter will not be edited next week. We apologize for any inconvenience for our subscribers and readers.     “Printemps Solidaire”, a French charity organization, in Paris Friday evening, with Bill and Melinda Gates as well […]

read more